ARV-102 reduced endolysosomal and neuroinflammatory biomarkers implicated in Parkinson’s disease and progressive supranuclear palsy –– ARV-102 ...

A rockstar who previously survived severe mental health battles is refusing cancer treatment, leaving them with ‘2-3 years’ ...

A Bolton dad has raised concern after his son was not told of the potential severity of lymphoma, an inquest heard.

Six months of trips to the hospital, chemotherapy, missing out on school and losing his hair, all led up to a moment ...

The friends and family of an ‘amazing’ and ‘inspiring’ woman who died from a brain tumour are taking on the Lewes Three Peaks challenge to raise money for The Royal Marsden Cancer Charity.

The Wildhearts frontman Ginger Wildheart won’t be seeking treatment after being diagnosed with a ‘rare and aggressive strain ...

CNS relapse occurred in 5.1% of adults with acute lymphoblastic leukaemia after transplant, with higher risk linked to Philadelphia chromosome positive disease.

Researchers from two labs in the Human Biology division at Fred Hutch Cancer Center recently published two studies aimed at better understanding how a notorious gene fusion — ZFTA-RELA — drives rare ...

A treatment regimen of penpulimab combined with rituximab, high-dose methotrexate, and cytarabine (Pen-RMA) achieved its primary endpoint in newly diagnosed primary central nervous system lymphoma ...

Debi Weiss went to the doctor's office with what she thought were worsening flu symptoms, but got a very different diagnosis ...

MRD testing promises sharper DLBCL response tracking than PET scans, cutting false positives, biopsies, and guiding therapy ...

Stage 1 mixed cellularity Hodgkin lymphoma is often highly treatable, and many patients achieve long-term remission after frontline therapy. Advances in chemotherapy, radiation techniques and targeted ...